C-terminal gp40 peptide analogs inhibit feline immunodeficiency virus: Cell fusion and virus spread

Journal of Virology

Volumn 76, Issue 18, 2002, Pages 9079-9086

  Medinas, R J ^a   Lambert, D M ^a   Tompkins, W A ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GLYCOPROTEIN; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 40; PROTEIN SUBUNIT; PROTEIN T20; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL FUSION; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; HELA CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; LENTIVIRINAE; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS CELL INTERACTION; VIRUS TRANSMISSION;

AMINO ACID SEQUENCE; ANIMALS; ANTIVIRAL AGENTS; CATS; CELL FUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; HELA CELLS; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; IMMUNODEFICIENCY VIRUS, FELINE; MEMBRANE FUSION; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLAQUE ASSAY; PROTEIN STRUCTURE, TERTIARY;

EID: 0036720982     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.18.9079-9086.2002     Document Type: Article

References (26)

1. A trimeric subdomain of the simian immunodeficiency virus envelope glycoprotein
2. A spring-loaded mechanism for the conformational change of influenza hemagglutinin
3. Core structure of gp41 from the HIV envelope glycoprotein
4. HIV entry and its inhibition
5. Spectroscopic determination of tryptophan and tyrosine in proteins
6. In vivo lymphocyte tropism of feline immunodeficiency virus
7. Binding of soluble CD4 proteins to human immunodeficiency virus type 1 and infected cells induces release of envelope glycoprotein gp120
8. Conformational changes in cell surface HIV-1 Envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors
9. Beitreg zur kollektiven behandlung pharmakologischer reihenversuche
10. Peptides from conserved regions of paramyxovirus fusion (f) proteins are potent inhibitors of viral fusion
11. HIV-1 membrane fusion mechanism: Structural studies of the interactions between biologically-active peptides from gp41
12. A trimeric structural domain of the HIV-1 transmembrane glycoprotein
13. Molecular characterization and heterogeneity of feline immunodeficiency virus isolates
14. Lymphocyte population changes in cats naturally infected with feline immunodeficiency virus
15. Isolation of a T-lymphotrophic virus from domestic cats with an immunodeficiency-like syndrome
16. Comparison of two host cell range variants of feline immuno-deficiency virus
17. Early events in the immunopathogenesis of feline retrovirus
18. New soluble-formazan assay for HIV-1 cytopathic effects: Application to high-flux screening of synthetic and natural products for AIDS-antiviral activity
19. Atomic structure of the ectodomain from HIV-1 gp41
20. A synthetic peptide inhibitor of human immunodeficiency virus replication: Correlation between solution structure and viral inhibition
21. Peptides corresponding to a predictive a-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection
22. Shared usage of the chemokine receptor CXCR4 by the feline and human immunodeficiency viruses
23. Patho-genesis of experimentally induced feline immunodeficiency virus infection in cats
24. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific-pathogen-free cats